These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12729513)

  • 1. When should travelers from nonendemic areas for flaviviruses receive booster vaccination for Japanese encephalitis?
    Kitchener S; Baade L; Brennan L
    J Travel Med; 2003; 10(1):50-1. PubMed ID: 12729513
    [No Abstract]   [Full Text] [Related]  

  • 2. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
    Guo W; Li L; Wu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
    Sricharoenchai S; Lapphra K; Chuenkitmongkol S; Phongsamart W; Bouckenooghe A; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
    Pediatr Infect Dis J; 2017 Feb; 36(2):e45-e47. PubMed ID: 27846060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term seroprotection against Japanese encephalitis using an inactivated vaccine (Jevax)].
    Van der Vliet D; Simons de Fanti A; Murri S; Lapidus N; Goujon C; Zeller H; Consigny PH
    Med Trop (Mars); 2010 Apr; 70(2):155-7. PubMed ID: 20486351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
    Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Japanese encephalitis: vaccination for some travelers to Asia useful and possible in The Netherlands].
    Kager PA
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1755-7. PubMed ID: 8396734
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further experience with Japanese encephalitis vaccine.
    Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW
    Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043
    [No Abstract]   [Full Text] [Related]  

  • 10. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
    Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
    Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low risk of Japanese encephalitis in short-term Australian travelers to Asia.
    Ratnam I; Leder K; Black J; Biggs BA; Matchett E; Padiglione A; Woolley I; Panagiotidis T; Gherardin T; Luxemburger C; Torresi J
    J Travel Med; 2013; 20(3):206-8. PubMed ID: 23577868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should travelers to Vietnam be vaccinated against japanese encephalitis?].
    Queuche F; Morillon M
    Med Trop (Mars); 1995; 55(1):102-3. PubMed ID: 7637595
    [No Abstract]   [Full Text] [Related]  

  • 15. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.
    Gambel JM; DeFraites R; Hoke C; Brown A; Sanchez J; Karabatsos N; Tsai T; Meschievitz C
    J Infect Dis; 1995 Apr; 171(4):1074. PubMed ID: 7706798
    [No Abstract]   [Full Text] [Related]  

  • 16. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should travellers to Asia be vaccinated against Japanese encephalitis?
    Denning DW; Kaneko Y
    Lancet; 1987 Apr; 1(8537):853-4. PubMed ID: 2882247
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2008; 52(4):219-24. PubMed ID: 19143477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemagglutination inhibition antibody against Japanese encephalitis virus and the effects of vaccination on inhabitants of Fukuoka City and its environs].
    Kobayashi Y; Ichiki T; Kusaba T; Tachibana N; Nagai K
    Kansenshogaku Zasshi; 1971 Nov; 45(11):490-3. PubMed ID: 4336811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.